Beraprost
Overview
As an analogue of prostacyclin PGI2, beraprost effects vasodilation, which in turn lowers the blood pressure.
Beraprost has a benzofuran ether function. This modification increases the plasma half-life from 30 seconds to several hours, and permits the compound to be taken orally. Its molecular formula is C24H29O5.Na.
Categories
No Categories Defined
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Beraprost's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 60 to 180 mcg | 120 (120) | As recommended. | PO | Begin by orally administered in three divided doses after meals a day. The highest dose is 180 microgram per day. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Beraprost is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Beraprost is available. |
High Risk Groups
Back to top
Warning / Precautions
No data regarding the Warnings/Precuations of Beraprost is available.
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Beraprost
Back to top
Previous Drug Generic - Next Drug Generic